About this trial

This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Thyroidectomy or bilateral thyroid resection of any indication

Written informed consent obtained after detailed patient information and provision of an information sheet

Disqualifiers

Age ≤ 18 years

Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause)

Previous surgery in the neck region

Pregnancy or breastfeeding

Trial design

Treatments tested in this trial

  • Active vitamin D
  • Calcium

Treatment groups

336 Participants
are divided into 2 treatment groups

Locations

1
Dept. Surgery I; University Hospital Wuerzburg97080, WürzburgBavaria, Germany

Sponsors and collaborators

Nicolas Schlegel

Lead sponsor

University of Wuerzburg

Sponsor institution

University of Wuerzburg

Collaborator